RP Management, LLC
- SEC CIK
- 0001507673
- Latest filing
- Aug 6, 2025
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 3
- 0 vs. Q2 2021
- Portfolio value
- $201.3M
- +$17.2M (+9.4%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 1,111,111 | $154.3M | 76.7% | 00.0% | Unchanged | History |
| EPZMEpizyme, Inc. | COM | 9,166,667 | $46.9M | 23.3% | 00.0% | Unchanged | History |
| VIRXViracta Therapeutics, Inc. | COM | 3,700 | $30.0K | <0.1% | 00.0% | Unchanged | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Epizyme Inc29428V904 | CALL | – | $13.0M |